M A Kay|K High - JoVE Visualize

Showing results (61-70 of 102) with videos related to

Pageof 11

Sort By:

The Journal of Clinical Investigation|November 15, 1996

Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoDC E Murry, M A Kay, T Bartosek, et al.

Human Gene Therapy|August 1, 1993

Assessment of recombinant adenoviral vectors for hepatic gene therapyQ Li, M A Kay, M Finegold, et al.

Gene Therapy|April 1, 1997

Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivoD B Schowalter, J C Tubb, M Liu, et al.

Gene Therapy|August 1, 1997

Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expressionD B Schowalter, L Meuse, C B Wilson, et al.

Nature Medicine|March 1, 1997

Recombinant adeno-associated virus for muscle directed gene therapyK J Fisher, K Jooss, J Alston, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 20, 1995

Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivoA Lieber, M J Vrancken Peeters, L Meuse, et al.

Cancer Gene Therapy|January 1, 1997

Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectorsK Brand, W Arnold, T Bartels, et al.

Journal of Virology|July 4, 2001

Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivoH Nakai, S R Yant, T A Storm, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 15, 1993

Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complexR J Cristiano, L C Smith, M A Kay, et al.

Journal of Virology|May 11, 1999

Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent miceD B Schowalter, C L Himeda, B L Winther, et al.

Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:

Pageof 11

The Journal of Clinical Investigation|November 15, 1996

Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoDC E Murry, M A Kay, T Bartosek, et al.

Human Gene Therapy|August 1, 1993

Assessment of recombinant adenoviral vectors for hepatic gene therapyQ Li, M A Kay, M Finegold, et al.

Gene Therapy|April 1, 1997

Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivoD B Schowalter, J C Tubb, M Liu, et al.

Gene Therapy|August 1, 1997

Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expressionD B Schowalter, L Meuse, C B Wilson, et al.

Nature Medicine|March 1, 1997

Recombinant adeno-associated virus for muscle directed gene therapyK J Fisher, K Jooss, J Alston, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 20, 1995

Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivoA Lieber, M J Vrancken Peeters, L Meuse, et al.

Cancer Gene Therapy|January 1, 1997

Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectorsK Brand, W Arnold, T Bartels, et al.

Journal of Virology|July 4, 2001

Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivoH Nakai, S R Yant, T A Storm, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 15, 1993

Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complexR J Cristiano, L C Smith, M A Kay, et al.

Journal of Virology|May 11, 1999

Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent miceD B Schowalter, C L Himeda, B L Winther, et al.

Pageof 11